Bio Path Holdings Inc
NASDAQ: BPTH
$2.81
+$0.05 (+1.8%)
Closing price May 9, 2024
BPTH Chart and Intraday Price
BPTH Company Data
| Asset Type | Common Stock |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | TRADE & SERVICES |
| Industry | RETAIL-MISCELLANEOUS SHOPPING GOODS STORES |
| Address | 2626 SOUTH LOOP, SUITE 180, HOUSTON, TX, US |
| Fiscal Year End | December |
| Latest Quarter | 2023-12-31 |
| Market Cap | 2.92M USD |
| Shares Outstanding | 678,800 |
BPTH Articles
Bio-Path stock has taken a beating in the past five years. Investors obviously aren’t happy about this, and the way that management and the board of directors has handled it has been clumsy.
Published:
Like all developmental drug companies, Bio-Path is betting on the success of its drug candidates. Drugs that are in trials often fail, so investors need to gamble that one or more of its treatments...
Published:
What is it like to have a stock plunge 90% in less than a year and wipe out a huge amount of shareholder value? That's what happened to Bio-Path.
Published: